The revolutionary in vitro diagnostic point-of-care platform
Abionic SA
Incorporated
04.10.2010Headquarters
EpalingesSupport
Abionic is a dynamic scale up company based in Switzerland, which is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology Lausanne, Switzerland), Abionic uses the most advanced technology to supply health care professionals with a novel point-of-care diagnostic tool. Abionic therewith gives access to immediate results for various diseases, for example the fastest test for early sepsis detection.
Sectors
Awards
News
FDA approvals and clinical advancements propel life sciences startups forward (startupticker.ch)
Startups welcome field experts in C-level roles (startupticker.ch)
Chinese pharma company secures exclusive licence with Abionic and Lascco (startupticker.ch)
The Swiss Medtech Award 2023 goes to Abionic (startupticker.ch)
Abionic receives IVDR certification for its ultra-rapid Sepsis test (startupticker.ch)
Clinical trial confirms Abionic’s ability to detect Sepsis earlier (startupticker.ch)
Abionic launches new tool for faster triage of Covid19 patients (startupticker.ch)
Le sepsis dans le viseur de la nouvelle étude clinique américaine d'Abionic (startupticker.ch)
Abionic announces successful completion of sepsis trial (startupticker.ch)
Abionic teams up with Genentech to develop rapid Asthma test (startupticker.ch)
Eighteen finalists nominated for the «Entrepreneur of the year» award (startupticker.ch)
Global visibility for Swiss startups (startupticker.ch)
Abionic Raises CHF20 Million in Series C Financing (startupticker.ch)
Top technologies and other strengths of Switzerland (startupticker.ch)
SEF4KMU: Die acht neuen Label-Träger 2017 (startupticker.ch)
Former Roche Diagnostics CSO and Biocartis Co-Founder join Abionic (startupticker.ch)
FDA Registration for Abionic?s Diagnostic Testing Platform (startupticker.ch)
World?s fastest sepsis test successfully tested in London and Zurich (startupticker.ch)
World’s fastest sepsis test successfully tested in London and Zurich (startupticker.ch)
Abionic to open distribution channel in the United Kingdom and Ireland (startupticker.ch)
Milestones news
LASCCO and Abionic Announce a Licensing Agreement with Fapon for PSP Sepsis Diagnosis in China
Abionic Receives CE Mark for Most Rapid Sepsis and Iron Deficiency Point of Care Diagnostics
Documents
Videos and Presentations
Discover Abionic's new infrastructures at Biopôle, Switzerland and words from Dr. Nicolas Durand, CEO.
SRF/ECO: Abionic ist einen Schritt weiter
Abionic featured on French TV channel ARTE
TV report from Reuters: Abioscope scratches itch for fast allergy testing
Abionic featured in the Polytech Ventures movie
Two million Swiss francs for an allergy-detecting device (EPFL movie)